You're Taking Vitamin D and Still Feeling Low. Here's the Biological Reason.

The VDR gene produces the vitamin D receptor, a protein found on nearly every cell in your body. This receptor is the lock and vitamin D is the key. When vitamin D binds to VDR, it unlocks a cascade of genetic instructions that regulate serotonin synthesis, dopamine metabolism, cortisol sensitivity, and the production of growth factors for brain health.

VDR variants, particularly the FokI polymorphism, determine how efficiently vitamin D can activate these downstream pathways. Individuals with certain VDR variants have receptors that are less responsive to vitamin D, meaning even adequate vitamin D levels may not trigger the full cascade of mood-supporting gene expression. You could have normal vitamin D blood levels yet impaired cellular response to that vitamin D at the receptor level.

This feels like hitting a ceiling: you supplement vitamin D, your blood test shows you’re adequate, but your mood doesn’t improve. You’re not imagining it. Your cells may simply not be responding as effectively as they should.

MTHFR converts folate (B9) into its active form, methylfolate, which then serves as a critical cofactor for the synthesis of serotonin, dopamine, and norepinephrine. Without active methylfolate, your body cannot produce adequate amounts of these neurotransmitters, no matter how much vitamin D you have or how healthy your lifestyle is.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme activity by 40-70%. This creates a functional folate deficiency at the cellular level, impairing your ability to synthesize mood-regulating neurotransmitters. Your folate blood test may look normal (it tests circulating folate, not cellular methylation capacity), but your cells are starved for the active form they actually use.

People with MTHFR variants who take standard folic acid supplements often feel worse, not better. Folic acid must be converted to methylfolate by MTHFR, but if your MTHFR is slow, this conversion stalls and folic acid accumulates. Meanwhile, your cells stay depleted of the methylfolate they actually need. Your mood doesn’t improve; sometimes it worsens.

COMT breaks down dopamine, norepinephrine, and epinephrine after these neurotransmitters have done their job. This is a critical housekeeping function: without proper clearance, these stress hormones remain active in your system, keeping you in a heightened arousal state. This is why COMT variants affect both mood and stress resilience.

The COMT Val158Met variant determines clearance speed. Roughly 25% of people with European ancestry are homozygous slow metabolizers (Met/Met genotype), meaning their COMT enzyme works slowly and dopamine and stress hormones linger. Even moderate stressors feel overwhelming, emotional reactivity is high, and you struggle to downregulate after a stressful event. Anxiety, emotional sensitivity, and persistent irritability are common. Some people with slow COMT describe feeling like they’re running on high alert constantly, even when nothing is actually threatening.

You might feel like you’re overreacting to small things, or that you can’t seem to calm down once you’re triggered. This isn’t a character flaw or a choice. It’s your COMT enzyme working slowly, leaving stress hormones elevated longer than they should be.

SLC6A4 produces the serotonin transporter protein, which sits on nerve cell membranes and pulls serotonin back into the cell after it’s been released. This recycling is critical because your brain doesn’t constantly make new serotonin; it reuses the serotonin it’s already made. The more efficiently serotonin is recycled, the longer it’s active in the synapse, and the steadier your mood.

The SLC6A4 short allele variant (5-HTTLPR short), carried by roughly 40% of people, impairs this recycling. Serotonin gets pulled back into the cell more slowly, leaving less time for it to signal and reducing effective serotonin activity in the brain. This variant is associated with higher baseline anxiety, lower stress resilience, and a greater likelihood of depression when life circumstances are difficult.

If you have the short allele, you may notice that small stressors feel larger, that worry persists longer than it does for others around you, or that you have difficulty bouncing back from disappointment. You might be described as sensitive or anxious. Your serotonin system is simply less efficient at maintaining steady mood tone.

BDNF is a growth factor that supports the survival of existing neurons and encourages the growth of new neurons and synapses, particularly in brain regions critical for mood regulation and stress resilience. BDNF is also required for antidepressants to work; without sufficient BDNF, even the best medication or supplement may fail to improve mood.

The BDNF Val66Met variant, present in roughly 30% of people, reduces the activity-dependent release of BDNF. This means your brain struggles to form new neural connections in response to experience, impairing both your ability to learn and your capacity to recover from depression or build emotional resilience. People with this variant often report that therapy or lifestyle changes don’t seem to “stick” the way they do for others; the neuroplasticity needed to rewire thought patterns is compromised.

You might have insight into what’s causing your low mood, you might even understand the cognitive distortions logically, but feel unable to change the pattern. This isn’t because you lack willpower or self-awareness. It’s that the biological machinery for building new neural connections is running slower than it should be.

SOD2 is an antioxidant enzyme located in the mitochondria of your cells. It breaks down superoxide, a dangerous free radical produced during energy production. The brain, especially regions involved in mood regulation like the prefrontal cortex and hippocampus, is highly metabolically active and vulnerable to oxidative stress. Without sufficient SOD2 activity, these regions accumulate oxidative damage, impairing their function.

The SOD2 Val16Ala variant, present in a significant portion of the population, reduces SOD2 enzyme activity. This leaves mood-regulating brain regions more vulnerable to oxidative stress and neuroinflammation, which are associated with depression and treatment-resistant mood disorders. The damage is often invisible on standard tests because it’s at the mitochondrial level; your inflammation markers and neurotransmitter levels might look fine, but cellular energy production and oxidative defense are compromised.

You might feel a persistent brain fog alongside your low mood, or notice that your energy crashes if you skip meals or exercise. Your mitochondria are working harder than they should to meet the energy demands of a brain that’s under oxidative stress.